Filing Details
- Accession Number:
- 0001127602-23-024300
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-18 16:06:23
- Reporting Period:
- 2023-09-15
- Accepted Time:
- 2023-09-18 16:06:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1682852 | Moderna Inc. | MRNA | Biological Products, (No Disgnostic Substances) (2836) | 813467528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760669 | Stephen Hoge | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-09-15 | 15,000 | $112.99 | 1,574,187 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,116 | Indirect | By Valhalla, LLC |
| Common Stock | 151,933 | Indirect | By Trust |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2023.
- These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
Billionaire Hedge Funds
